Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1985 Aug;49(2):447–451. doi: 10.1128/iai.49.2.447-451.1985

Relationship between delayed hypersensitivity response and acquired cell-mediated immunity in C57BL/6J mice infected with Leishmania donovani.

J R Fahey, R Herman
PMCID: PMC262039  PMID: 4018876

Abstract

The relationship between the development of acquired cell-mediated immunity and the concomitant level of specific delayed hypersensitivity (DH) in C57BL/6J mice infected with the intracellular protozoan parasite Leishmania donovani was studied. It was determined that the intradermal injection of Leishmania antigen (heat- or phenol-killed flagellated forms of L. donovani) could elicit a DH response as early as day 10 and as late as day 120 postinfection in mice infected by the intravenous route. Dose-response studies showed that there is an inverse relationship between the size of the infecting dose of parasites and the magnitude of the DH response. Thus, increasing the degree of infection depressed the DH response. This depression, however, could be abrogated by treatment of mice with cyclophosphamide (201 mg/kg) before intradermal injection of antigen.

Full text

PDF
447

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Askenase P. W., Hayden B. J., Gershon R. K. Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J Exp Med. 1975 Mar 1;141(3):697–702. doi: 10.1084/jem.141.3.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Belehu A., Poulter L. W., Turk J. L. Modification of cutaneous leishmaniasis in the guinea-pig by cyclophosphamide. Clin Exp Immunol. 1976 Apr;24(1):125–132. [PMC free article] [PubMed] [Google Scholar]
  3. Bradley D. J. Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection. Clin Exp Immunol. 1977 Oct;30(1):130–140. [PMC free article] [PubMed] [Google Scholar]
  4. Bryceson A. D., Bray R. S., Dumonde D. C. Experimental cutaneous leishmaniasis. IV. Selective suppression of cell-mediated immunity during the response of guinea-pigs to infection with Leishmania enriettii. Clin Exp Immunol. 1974 Feb;16(2):189–202. [PMC free article] [PubMed] [Google Scholar]
  5. Buhles W. C., Jr, Shifrine M. Effects of cyclophosphamide on macrophage numbers, functions and progenitor cells. J Reticuloendothel Soc. 1977 May;21(5):285–297. [PubMed] [Google Scholar]
  6. Collins F. M., Mackaness G. B. Delayed hypersensitivity and arthus reactivity in relation to host resistance in salmonella-infected mice. J Immunol. 1968 Nov;101(5):830–845. [PubMed] [Google Scholar]
  7. Collins F. M., Mackaness G. B. The relationship of delayed hypersensitivity to acquired antituberculous immunity. I. Tuberculin sensitivity and resistance to reinfection in BCG-vaccinated mice. Cell Immunol. 1970 Sep;1(3):253–265. doi: 10.1016/0008-8749(70)90047-x. [DOI] [PubMed] [Google Scholar]
  8. Cottney J., Bruin J., Lewis A. J. Modulation of the immune system in the mouse. 1. Drug administration prior to antigen sensitization. Agents Actions. 1980 Sep;10(4):378–388. doi: 10.1007/BF01971444. [DOI] [PubMed] [Google Scholar]
  9. Curtis J., Adu H. O., Turk J. L. A lack of correlation between antigen-specific cellular reactions and resistance to Mycobacterium lepraemurium infection in mice. Immunology. 1981 Jun;43(2):293–301. [PMC free article] [PubMed] [Google Scholar]
  10. DeTolla L. J., Scott P. A., Farrell J. P. Single gene control of resistance to cutaneous leishmaniasis in mice. Immunogenetics. 1981;14(1-2):29–39. doi: 10.1007/BF00344297. [DOI] [PubMed] [Google Scholar]
  11. Escande A., Cannat A., Serre A. Dissociation of delayed-type hypersensitivity from acquired murine resistance to Brucella suis. Ann Immunol (Paris) 1980 Sep-Oct;131D(2):199–204. [PubMed] [Google Scholar]
  12. Herman R. Cytophilic and opsonic antibodies in visceral leishmaniasis in mice. Infect Immun. 1980 May;28(2):585–593. doi: 10.1128/iai.28.2.585-593.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Heyneman D. Immunology of leishmaniasis. Bull World Health Organ. 1971;44(4):499–514. [PMC free article] [PubMed] [Google Scholar]
  14. Hurtrel B., Langrange P. H., Michel J. C. Absence of correlation between delayed-type hypersensitivity and protection in experimental systemic candidiasis in immunized mice. Infect Immun. 1981 Jan;31(1):95–101. doi: 10.1128/iai.31.1.95-101.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Keithly J. S. Infectivity of Leishmania donovani amastigotes and promastigotes for golden hamsters. J Protozool. 1976 May;23(2):244–245. doi: 10.1111/j.1550-7408.1976.tb03763.x. [DOI] [PubMed] [Google Scholar]
  16. Kerckhaert J. A., Van den Berg G. J., Willers J. M. Influence of cyclophosphamide on the delayed hypersensitivity of the mouse. Ann Immunol (Paris) 1974 Mar-Apr;125(3):415–426. [PubMed] [Google Scholar]
  17. Lagrange P. H., Mackaness G. B., Miller T. E. Influence of dose and route of antigen injection on the immunological induction of T cells. J Exp Med. 1974 Mar 1;139(3):528–542. doi: 10.1084/jem.139.3.528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lagrange P. H., Mackaness G. B., Miller T. E. Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med. 1974 Jun 1;139(6):1529–1539. doi: 10.1084/jem.139.6.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Liew F. Y., Howard J. G., Hale C. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH. J Immunol. 1984 Jan;132(1):456–461. [PubMed] [Google Scholar]
  20. MACKANESS G. B. Cellular resistance to infection. J Exp Med. 1962 Sep 1;116:381–406. doi: 10.1084/jem.116.3.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. MACKANESS G. B. THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE. J Exp Med. 1964 Jul 1;120:105–120. doi: 10.1084/jem.120.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. MANSON-BAHR P. E., HEISCH R. B., GARNHAM P. C. Studies in leishmanifasis in East Africa. IV. The Montenegro test in kala-azar in Kenya. Trans R Soc Trop Med Hyg. 1959 Sep;53:380–383. doi: 10.1016/0035-9203(59)90038-0. [DOI] [PubMed] [Google Scholar]
  23. Marbrook J., Baguley B. C. The recovery of immune responsiveness after treatment with cyclophosphamide. Int Arch Allergy Appl Immunol. 1971;41(6):802–812. doi: 10.1159/000230572. [DOI] [PubMed] [Google Scholar]
  24. McDonald V., Sherman I. W. Lack of correlation between delayed-type hypersensitivity and host resistance to Plasmodium chabaudi infection. Clin Exp Immunol. 1980 Dec;42(3):421–427. [PMC free article] [PubMed] [Google Scholar]
  25. Poulter L. W., Lefford M. J. Relationship between delayed-type hypersensitivity and the progression of Mycobacterium lepraemurium infection. Infect Immun. 1978 May;20(2):530–540. doi: 10.1128/iai.20.2.530-540.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Poulter L. W. Mechanisms of immunity to leishmaniasis. II. Significance of the intramacrophage localization of the parasite. Clin Exp Immunol. 1980 Apr;40(1):25–35. [PMC free article] [PubMed] [Google Scholar]
  27. Preston P. M., Behbehani K., Dumonde D. C. Experimental cutaneous leishmaniasis: VI: anergy and allergy in the cellular immune response during non-healing infection in different strains of mice. J Clin Lab Immunol. 1978 Nov;1(3):207–219. [PubMed] [Google Scholar]
  28. Preston P. M., Dumonde D. C. Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse. Clin Exp Immunol. 1976 Jan;23(1):126–138. [PMC free article] [PubMed] [Google Scholar]
  29. Rezai H. R., Farrell J., Soulsby E. L. Immunological responses of L. donovani infection in mice and significance of T cell in resistance to experimental leishmaniasis. Clin Exp Immunol. 1980 Jun;40(3):508–514. [PMC free article] [PubMed] [Google Scholar]
  30. Schwartz A., Askenase P. W., Gershon R. K. Regulation of delayed-type hypersensitivity reactions by cyclophosphamide-sensitive T cells. J Immunol. 1978 Oct;121(4):1573–1577. [PubMed] [Google Scholar]
  31. Scott P. A., Farrell J. P. Experimental cutaneous leishmaniasis: disseminated leishmaniasis in genetically susceptible and resistant mice. Am J Trop Med Hyg. 1982 Mar;31(2):230–238. doi: 10.4269/ajtmh.1982.31.230. [DOI] [PubMed] [Google Scholar]
  32. Skov C. B., Twohy D. W. Cellular immunity to Leishmania donovani. I. The effect of T cell depletion on resistance to L. donovani in mice. J Immunol. 1974 Dec;113(6):2004–2011. [PubMed] [Google Scholar]
  33. Skov C. B., Twohy D. W. Cellular immunity to Leishmania donovani. II. Evidence for synergy between thymocytes and lymph node cells in reconstitution of acquired resistance to L. donovani in mice. J Immunol. 1974 Dec;113(6):2012–2019. [PubMed] [Google Scholar]
  34. Smrkovski L. L., Larson C. L., Reed S. G. Effect of visceral leishmaniasis on congenitally athymic mice. Infect Immun. 1979 Sep;25(3):1078–1080. doi: 10.1128/iai.25.3.1078-1080.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Stauber L. A. Characterization of strains of Leishmania donovani. Exp Parasitol. 1966 Feb;18(1):1–11. doi: 10.1016/0014-4894(66)90002-6. [DOI] [PubMed] [Google Scholar]
  36. TOBIE E. J., VON BRAND T., MEHLMAN B. Cultural and physiological observations on Trypanosoma rhodesiense and Trypanosoma gambiense. J Parasitol. 1950 Feb;36(1):48–54. [PubMed] [Google Scholar]
  37. Titus R. G., Lima G. C., Engers H. D., Louis J. A. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity. J Immunol. 1984 Sep;133(3):1594–1600. [PubMed] [Google Scholar]
  38. Turk J. L., Poulter L. W. Effects of cyclophosphamide on lymphoid tissues labelled with 5-iodo-2-deoxyuridine- 125 I and 51 Cr. Int Arch Allergy Appl Immunol. 1972;43(4):620–629. doi: 10.1159/000230874. [DOI] [PubMed] [Google Scholar]
  39. Turk J. L., Poulter L. W. Selective depletion of lymphoid tissue by cyclophosphamide. Clin Exp Immunol. 1972 Feb;10(2):285–296. [PMC free article] [PubMed] [Google Scholar]
  40. Ulczak O. M., Blackwell J. M. Immunoregulation of genetically controlled acquired responses to Leishmania donovani infection in mice: the effects of parasite dose, cyclophosphamide and sublethal irradiation. Parasite Immunol. 1983 Sep;5(5):449–463. doi: 10.1111/j.1365-3024.1983.tb00760.x. [DOI] [PubMed] [Google Scholar]
  41. Willers J. M., Sluis E. The influence of cyclophosphamide on antibody formation in the mouse. Ann Immunol (Paris) 1975 Apr;126(3):267–279. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES